GeneDx Hit with Class Action Lawsuit Over Fabric Genomics Acquisition
WGS has more than doubled off its 52-week low of $32.21.
Summary
GeneDx Holdings is facing a securities class action lawsuit from Hagens Berman, alleging the company misled investors about its Fabric Genomics acquisition. This follows a 49% stock collapse in May after a Q1 earnings report revealed a $31.2 million impairment charge related to the acquisition. The lawsuit claims GeneDx falsely promoted the acquisition's synergy and profitability, leading to investor losses. The lead plaintiff deadline is August 3, 2026.
At the time of this announcement, WGS was trading at $65.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $32.21 to $170.87. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.